Evidence map›Paper›PMID 34840644›Full record

ArticleThe Journal of clinical and aesthetic dermatology2021

Biophotonic Therapy with Fluorescent Light Energy Decreases Facial Erythema, Improves Signs and Symptoms of Rosacea, and Increases Patient Satisfaction: A Postmarket Study.

Martin Wade, Vanessa Charest, Bruno Ballardin, Deirdre Edge, Michael Canova Engelbrecht Nielsen

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Martin WadeDr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England.
Vanessa CharestDr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England.
Bruno BallardinDr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England.
Deirdre EdgeDr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England.
Michael Canova Engelbrecht NielsenDr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England.
London Clinic · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRosacea is a difficult-to-manage chronic inflammatory skin condition reported to have a negative psychosocial impact on patients. Novel approaches are sought to target the many signs and symptoms of the condition while also improving the quality of life of patients.

objectiveWe assessed the efficacy of the Kleresca

methodsNine patients were treated once a week for four weeks with FLE. Patients and the treating clinician completed questionnaires throughout and after the treatment to grade the rosacea signs and symptoms and capture patients' perceptions of the treatment and their condition.

resultsFLE significantly reduced the inflammatory erythematous reaction of the face, improved flushing and erythema associated with rosacea, and had a positive impact on patients' self-perception and emotional wellbeing.

conclusionOur results support FLE as an effective, noninvasive treatment modality for rosacea.

Indexed as

biophotonicschromophoreerythemaFLEfluorescent light energyflushinginflammatory skin conditionspatient perceptionphotobiomodulationquality of lifequestionnaireRosaceaskin quality

Identifiers

PMID34840644
PMCPMC8570353
OpenAlexW3217382656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.